Helix Biopharma Corp (HBPCF) 1.3902 $HBPCF Helix

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Helix Biopharma Corp (HBPCF) 1.3902 $HBPCF

Helix BioPharma Corp. Closes CAD1.8 Million Private Placement
Marketwired - Fri Jul 29, 3:01PM CDT
AURORA, ON--(Marketwired - Jul 29, 2016) -  Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for aggregate gross proceeds of approximately CAD1.8 million.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Announces Agreement in Principle With National Research Council of Canada to Collaborate on Various Immuno-Oncology Initiatives
Marketwired - Mon Jul 18, 3:10PM CDT
AURORA, ON--(Marketwired - Jul 18, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced that an Agreement in Principle ("Agreement" has been reached with the National Research Council of Canada ("NRC" to collaborate on various immuno-oncology initiatives.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Appoints Evolution Life Science Partners as Advisors
Marketwired - Thu Jun 02, 7:00AM CDT
AURORA, ON--(Marketwired - Jun 2, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Evolution Life Science Partners to act as advisors to the Company. Activities the Company may pursue could include, but are not limited to, partnering or other collaboration agreements. The Company does not intend to disclose developments with respect to this process except as required under applicable securities regulations.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

First Patient Dosed in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Wed May 11, 6:30AM CDT
AURORA, ON--(Marketwired - May 11, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the first patient was dosed in the Phase II component of study LDOS002.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Subsidiary, Helix Polska Sp zo.o., Qualifies for CAD4.1 Million Grant From the Polish National Center for Research and Development
Marketwire Canada - Mon May 09, 6:30AM CDT
AURORA, ON--(Marketwired - May 9, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that its wholly owned subsidiary, Helix Polska Sp. z o.o. qualifies for a grant of approximately PLN12.5mil from the Polish National Centre for Research and Development to develop V-DOS47 in breast cancer. The acceptance of the grant is subject to review and approval of the final terms and conditions by Helix's management and Board of Directors and may be subject to conditions imposed by the granting authority and corporate or other approvals.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Closes CAD4.7 Million Private Placement Financing
Marketwired - Fri Apr 29, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for aggregate gross proceeds of approximately CAD4.7 million.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

First Patient Enrolled in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 28, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the first patient has been enrolled in the Phase II component of study LDOS002.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Trial Steering Committee Recommends Initiation of Phase II L-DOS47 Study in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 21, 4:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the recommendation by the Trial Steering Committee to initiate the Phase II component of the LDOS002 study.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Announces Important Additions to Its Leadership Team
Marketwire Canada - Wed Apr 20, 6:30PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Dr. Patrick Frankham to Chief Operating Officer and the promotion of Mr. Steve Demas to the position of Chief Medical Officer. Dr. Frankham and Mr. Demas will both report directly to Dr. Sven Rohmann, Helix's newly appointed Chief Executive Officer.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix Biopharma Corp. Announces the Receipt of Subscription Agreements Totalling CAD4.7 Million for Private Placement Financing
Marketwire Canada - Fri Apr 15, 6:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company", a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for units for aggregate gross proceeds of approximately CAD4.7 million.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix BioPharma Corp. Announces CEO Change
Marketwire Canada - Tue Mar 29, 3:46PM CDT
Helix BioPharma Corp. (hereinafter defined as "Helix" or the "Company" (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, announces that Dr. Zbigniew Markowski will be stepping down, for personal and family reasons, from his positions as Chief Executive Officer of Helix BioPharma Corp and Chairman of Helix Polska, effective March 29th, 2016. Stepping into both roles, effective immediately, will be Dr. Sven Rohmann.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Helix Biopharma Corp. Announces Second Quarter Fiscal 2016 Results
Marketwire Canada - Wed Mar 16, 3:15PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the second quarter of fiscal 2016, ended January 31, 2016.
HBP: 6.02 (+0.24), HBP.TO: 1.96 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 0

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 48

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 43

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 58

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 18

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 46

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 183

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 52

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 97

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 20

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading

Top 5 Most Recently Viewed Articles

E-commerce Brands Make Striking Debut at Fashion Week

Updated Category News Views 96

E-commerce Brands Shine at Fashion Week In an exciting turn for the fashion world, online powerhouses Coofandy and Ekouaer have made a memorable entrance at New York Fashion Week (NYFW). They brought along the star power of supermodels Helena Christensen and Sean O'Pry to help spotlight their brands. Coofandy, known for its stylish menswear, and Ekouaer, which specializes...

Continue Reading
Tallinna Vesi Plans To Adjust Water Service Prices in 2025

Updated Category News Views 182

Tallinna Vesi Plans Adjustment of Water Supply Prices for 2025 Tallinna Vesi has submitted an application to change the prices of its water supply services, pending approval from the Competition Authority. The changes, projected to take effect in 2025, are rooted in legal requirements to standardize pricing for both private and business customers. This initiative aims to...

Continue Reading
Investor Insights: Bullish Moves in PDD Holdings Options

Updated Category News Views 131

Unusual Options Activity in PDD Holdings In recent trading sessions, investors with substantial capital have taken a bullish stance toward PDD Holdings (NASDAQ: PDD). This behavior is drawing significant attention in the financial landscape, suggesting that noteworthy changes may be on the horizon. Our latest findings highlight this trend and delve into the implications...

Continue Reading
AI and Software Spending Surge: Insights for Businesses in 2025

Updated Category News Views 426

AI and Software Spending Trends Shaping 2025 As companies continue to adapt to evolving market demands, one thing has become abundantly clear: software spending is on the rise. The landscape of corporate technology acquisitions has changed dramatically, with a reported increase of 10% in software spending in recent times. This growth mirrors the increasing integration of...

Continue Reading
Unleashing Summer Fun: Kinder Chocolate and Paul George Unite

Updated Category News Views 227

Refreshing Summer with Kinder Chocolate's Brand Campaign In a delightful move that captures the essence of summer joy, Kinder Chocolate is launching a vibrant campaign called Pass The Fun. With an exciting collaboration featuring NBA All-Star Paul George, the campaign promises to spark joyful moments for families and kids through basketball this summer. This initiative...

Continue Reading